Nomura Asset Management CO LTD Aerie Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

9 transactions

Quarter	Operation	Price Per share	shares change
Q3 2019 Nov 13, 2019	SELL	$18.41 - $28.0 $0 - $0	0 Closed
Q2 2019 Aug 13, 2019	BUY	$28.97 - $48.21 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$36.32 - $49.25 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$36.32 - $49.25 $0 - $0	0 New
Q4 2018 Feb 12, 2019	BUY	$33.0 - $60.04 $0 - $0	0 New
Q3 2018 Nov 07, 2018	BUY	$56.15 - $73.9 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$47.85 - $70.45 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$51.15 - $61.0 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $0 - $0	0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.